• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于定量表达与Higuchi模型偏差的新型数学方法。

Novel mathematical method for quantitative expression of deviation from the higuchi model.

作者信息

Gohel M C, Panchal M K, Jogani V V

机构信息

Department of Pharmaceutics, L.M. College of Pharmacy, P.O. Box. No. 4011, Navrangpura, Ahmedabad-380009, India.

出版信息

AAPS PharmSciTech. 2000 Oct 28;1(4):E31. doi: 10.1208/pt010431.

DOI:10.1208/pt010431
PMID:14727896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2750455/
Abstract

A simple mathematical method to express the deviation in release profile of a test product following Higuchi's kinetics from an ideal Higuchi release profile was developed. The method is based on calculation of area under the curve (AUC) by using the trapezoidal rule. The precision of prediction depends on the number of data points. The method is exemplified for 2 dosage forms (tablets of diltiazem HCl and microspheres of diclofenac sodium) that are designed to release the drug over a 12-hour period. The method can be adopted for the formulations where drug release is incomplete (<100%) or complete (100%) at last sampling time. To describe the kinetics of drug release from the test formulation, zero-order, first-order, Higuchi's, Hixson-Crowell's, and Weibull's models were used. The criterion for selecting the most appropriate model was based on the goodness-of-fit test. The release kinetics of the tablets and microspheres were explained by the Higuchi model. The release profiles of the test batches were slightly below the ideal Higuchi release profile. For the test products, observed percentage deviation from an ideal Higuchi profile is less than 16% for tablets and less than 11% for microspheres. The proposed method can be extended to the modified release formulations that are designed to release a drug over 6, 18, or 24 hours. If the data points are not evenly separated, the ideal drug release profile and AUC are calculated according to the specific sampling time. The proposed method may be used for comparing formulated products during the research and development stage, for quality control of the products, or for promoting products by comparing performance of the test product with that of the innovator's product.

摘要

开发了一种简单的数学方法,用于表示遵循Higuchi动力学的测试产品释放曲线与理想Higuchi释放曲线之间的偏差。该方法基于使用梯形法则计算曲线下面积(AUC)。预测精度取决于数据点的数量。以2种剂型(盐酸地尔硫卓片和双氯芬酸钠微球)为例进行说明,这两种剂型设计为在12小时内释放药物。该方法可用于在最后采样时间药物释放不完全(<100%)或完全(100%)的制剂。为了描述测试制剂中药物释放的动力学,使用了零级、一级、Higuchi、Hixson-Crowell和Weibull模型。选择最合适模型的标准基于拟合优度检验。片剂和微球的释放动力学由Higuchi模型解释。测试批次的释放曲线略低于理想的Higuchi释放曲线。对于测试产品,观察到的与理想Higuchi曲线的百分比偏差,片剂小于16%,微球小于11%。所提出的方法可扩展到设计为在6、18或24小时内释放药物的缓释制剂。如果数据点不是均匀分布的,则根据特定的采样时间计算理想的药物释放曲线和AUC。所提出的方法可用于在研发阶段比较配方产品、产品的质量控制,或通过比较测试产品与创新产品的性能来推广产品。

相似文献

1
Novel mathematical method for quantitative expression of deviation from the higuchi model.一种用于定量表达与Higuchi模型偏差的新型数学方法。
AAPS PharmSciTech. 2000 Oct 28;1(4):E31. doi: 10.1208/pt010431.
2
In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.双氯芬酸钠从生物聚合物亲水性基质中的体外控释研究。
J Pharm Pharm Sci. 2002 Sep-Dec;5(3):213-9.
3
[The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].[天然及合成亲水性聚合物在不同释放曲线盐酸二甲双胍片制剂中的应用]
Polim Med. 2012;42(3-4):167-84.
4
Formulation development and in vitro evaluation of theophylline microcapsules.茶碱微胶囊的制剂研发与体外评价
Pak J Pharm Sci. 2012 Jan;25(1):15-9.
5
[Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].[双氯芬酸钠缓释制剂中所选药物的技术和药物治疗特性]
Polim Med. 2012;42(2):121-32.
6
Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.对三种市售盐酸地尔硫卓缓释片进行溶出度等效性测试。
Acta Pol Pharm. 2010 Jan-Feb;67(1):93-7.
7
Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.双氯芬酸钠缓释片制剂的制备及体外评价
Farmaco. 2005 Feb;60(2):171-7. doi: 10.1016/j.farmac.2004.10.001. Epub 2005 Jan 7.
8
Pharmaceutical Product Lead Optimization for Better In vivo Bioequivalence Performance: A case study of Diclofenac Sodium Extended Release Matrix Tablets.优化药品以实现更好的体内生物等效性表现:双氯芬酸钠缓释骨架片的案例研究
Curr Drug Deliv. 2018;15(5):705-715. doi: 10.2174/1567201814666171120124551.
9
Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.使用羟丙基甲基纤维素评估布洛芬骨架片的药物释放动力学。
Pak J Pharm Sci. 2006 Apr;19(2):119-24.
10
Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums.使用PVP-K90和天然胶体制备双氯芬酸钠缓释骨架片并进行体外-体内评价
Pak J Pharm Sci. 2011 Oct;24(4):435-43.

引用本文的文献

1
Modified starch as a new co-excipient in hydrophilic gels for prolonged drug delivery.改性淀粉作为亲水性凝胶中用于延长药物释放的新型共辅料。
Sci Rep. 2025 Jun 2;15(1):19255. doi: 10.1038/s41598-025-88179-x.
2
Exploring Advanced CRISPR Delivery Technologies for Therapeutic Genome Editing.探索用于治疗性基因组编辑的先进CRISPR递送技术。
Small Sci. 2024 Jul 25;4(10):2400192. doi: 10.1002/smsc.202400192. eCollection 2024 Oct.
3
Temperature-Sensitive Fragrance Microcapsules with Double Capsule Walls: A Study on Preparation and Sustained Release Mechanism.具有双层囊壁的温敏香料微胶囊:制备及缓释机制研究
Polymers (Basel). 2023 Sep 7;15(18):3686. doi: 10.3390/polym15183686.
4
Modified Potato Starch as a Potential Retardant for Prolonged Release of Lidocaine Hydrochloride from Methylcellulose Hydrophilic Gel.改性马铃薯淀粉作为一种潜在的阻滞剂用于从甲基纤维素亲水凝胶中延长盐酸利多卡因的释放。
Pharmaceutics. 2023 Jan 23;15(2):387. doi: 10.3390/pharmaceutics15020387.
5
Development of Perphenazine-Loaded Solid Lipid Nanoparticles: Statistical Optimization and Cytotoxicity Studies.载奋乃静固体脂质纳米粒的制备:统计学优化及细胞毒性研究。
Biomed Res Int. 2021 Apr 28;2021:6619195. doi: 10.1155/2021/6619195. eCollection 2021.
6
Effects of Compositional Tailoring on Drug Delivery Behaviours of Silica Xerogel/Polymer Core-shell Composite Nanoparticles.复合调控制对二氧化硅气凝胶/聚合物核壳复合纳米粒子药物传递行为的影响。
Sci Rep. 2018 Aug 29;8(1):13002. doi: 10.1038/s41598-018-31070-9.
7
Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine.那可丁甘露糖化自乳化固体分散体的处方、药代动力学及药效学研究
PLoS One. 2016 Jan 12;11(1):e0146804. doi: 10.1371/journal.pone.0146804. eCollection 2016.
8
Solid lipid nanoparticles of a water soluble drug, ciprofloxacin hydrochloride.水溶性药物盐酸环丙沙星的固体脂质纳米粒
Indian J Pharm Sci. 2012 Sep;74(5):434-42. doi: 10.4103/0250-474X.108419.
9
Hydrocortisone Diffusion Through Synthetic Membrane, Mouse Skin, and Epiderm™ Cultured Skin.氢化可的松透过合成膜、小鼠皮肤和Epiderm™培养皮肤的扩散情况。
Arch Drug Inf. 2011 Mar;4(1):10-21. doi: 10.1111/j.1753-5174.2010.00033.x.

本文引用的文献

1
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.缓释药物的作用机制。分散于固体基质中的固体药物释放速率的理论分析。
J Pharm Sci. 1963 Dec;52:1145-9. doi: 10.1002/jps.2600521210.
2
Rate of release of medicaments from ointment bases containing drugs in suspension.含有混悬药物的软膏基质中药物的释放速率。
J Pharm Sci. 1961 Oct;50:874-5. doi: 10.1002/jps.2600501018.
3
An exponential expression for in vitro release of drug from sustained-release preparations.用于描述药物从缓释制剂中体外释放的指数表达式。
Drug Stand. 1959 Nov-Dec;27:165-71.
4
Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations.亲水性天然胶微基质制剂中溶胀、侵蚀与药物释放之间的关系。
Eur J Pharm Sci. 1998 Jul;6(3):207-17. doi: 10.1016/s0928-0987(97)00072-9.
5
Formulation optimization of controlled release diclofenac sodium microspheres using factorial design.采用析因设计对双氯芬酸钠控释微球进行处方优化。
J Control Release. 1998 Feb 12;51(2-3):115-22. doi: 10.1016/s0168-3659(97)00102-8.
6
Square root of time dependence of matrix formulations with low drug content.低药物含量基质制剂的时间依赖性平方根。
J Pharm Sci. 1982 Jul;71(7):749-52. doi: 10.1002/jps.2600710708.